Small molecules proceed to play a serious half in pharmaceutical growth, however rising molecular complexity, accelerated timelines, and evolving manufacturing and regulatory necessities are creating new challenges for the trade.
On this GEN Podcast – half 2 in a 3-part sequence – a trio of specialists from SK Pharmteco focus on how CDMOs are serving to biopharma firms navigate vital areas together with scale-up, know-how switch, superior manufacturing, automation, sustainability, the emergence of AI, and provide chain reliability. The dialogue explores sensible methods for bettering growth effectivity whereas supporting high quality, scalability, and long-term industrial success.
Podcast Friends:
Steve Barr, PhDHead of Small Molecule Enterprise Unitand VP International AlliancesSK pharmteco
Darryl RattyExecutive Director of International ESGESG (Environmental, Social and Governance)SK pharmteco
Invoice DuBayVice President,International Analysis and DevelopmentSK pharmteco
Produced with help from:
